Platelet factor 4 limits neutrophil extracellular trap– and cell-free DNA–induced thrombogenicity and endothelial injury

Plasma cell-free DNA (cfDNA), a marker of disease severity in sepsis, is a recognized driver of thromboinflammation and a potential therapeutic target. In sepsis, plasma cfDNA is mostly derived from neutrophil extracellular trap (NET) degradation. Proposed NET-directed therapeutic strategies include preventing NET formation or accelerating NET degradation. However, NET digestion liberates pathogens and releases cfDNA that promote thrombosis and endothelial cell injury. We propose an alternative strategy of cfDNA and NET stabilization with chemokine platelet factor 4 (PF4, CXCL4). We previously showed that human PF4 (hPF4) enhances NET-mediated microbial entrapment. We now show that hPF4 interferes with thrombogenicity of cfDNA and NETs by preventing their cleavage to short-fragment and single-stranded cfDNA that more effectively activates the contact pathway of coagulation. In vitro, hPF4 also inhibits cfDNA-induced endothelial tissue factor surface expression and von Willebrand factor release. In vivo, hPF4 expression reduced plasma thrombin-antithrombin (TAT) levels in animals infused with exogenous cfDNA. Following lipopolysaccharide challenge, Cxcl4–/– mice had significant elevation in plasma TAT, cfDNA, and cystatin C levels, effects prevented by hPF4 infusion. These results show that hPF4 interacts with cfDNA and NETs to limit thrombosis and endothelial injury, an observation of potential clinical benefit in the treatment of sepsis.

[1]  A. Wu,et al.  Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information. , 2022, Clinical chemistry.

[2]  M. Pellegrini,et al.  Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA , 2022, iScience.

[3]  Y. Lo,et al.  Cell-Free DNA Fragmentomics in Liquid Biopsy , 2022, Diagnostics.

[4]  S. Lyons,et al.  Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection , 2022, JCI insight.

[5]  G. Pierce,et al.  DNase 1 Protects From Increased Thrombin Generation and Venous Thrombosis During Aging: Cross‐Sectional Study in Mice and Humans , 2022, Journal of the American Heart Association.

[6]  Thomas Maiberger,et al.  cfDNA and DNases: New Biomarkers of Sepsis in Preterm Neonates—A Pilot Study , 2022, Cells.

[7]  H. Nakaya,et al.  Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation. , 2021, Blood.

[8]  J. Malmstrom,et al.  Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients , 2021, Molecular & Cellular Proteomics.

[9]  W. Ding,et al.  Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway , 2021, Cell Death & Disease.

[10]  D. Dwivedi,et al.  Mechanistic Studies of DNase I Activity: Impact of Heparin Variants and PAD4 , 2021, Shock.

[11]  S. Harding,et al.  Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction , 2021, Thrombosis and Haemostasis.

[12]  C. Darwish,et al.  The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome , 2021, Critical care research and practice.

[13]  P. Jiang,et al.  Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies , 2021, Science.

[14]  Baihai Su,et al.  Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets , 2021, Frontiers in Immunology.

[15]  P. King,et al.  Phagocyte extracellular traps in children with neutrophilic airway inflammation , 2021, ERJ Open Research.

[16]  G. López-Cortés,et al.  Multiple Origins of Extracellular DNA Traps , 2021, Frontiers in Immunology.

[17]  Ranran Wang,et al.  Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke , 2021, Blood.

[18]  R. Teruel-Montoya,et al.  Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms , 2021, International journal of molecular sciences.

[19]  H. Philippou,et al.  Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI , 2021, Proceedings of the National Academy of Sciences.

[20]  Jianmin Gu,et al.  Inhibition of Peptidyl Arginine Deiminase-4 Prevents Renal Ischemia-Reperfusion-Induced Remote Lung Injury , 2020, Mediators of inflammation.

[21]  Aaron M Williams,et al.  Cl-Amidine Improves Survival and Attenuates Kidney Injury in a Rabbit Model of Endotoxic Shock. , 2020, Surgical infections.

[22]  M. Hémadi,et al.  Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.

[23]  Robert A. Campbell,et al.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome , 2020, Blood.

[24]  Veroniki P. Vidali,et al.  Ticagrelor Exerts Immune-Modulatory Effect by Attenuating Neutrophil Extracellular Traps , 2020, International journal of molecular sciences.

[25]  N. Barbarroja,et al.  Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness , 2020, Journal of Biomedical Science.

[26]  Jinming Li,et al.  Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing , 2020, Theranostics.

[27]  Yang Liu,et al.  Microbial cell-free DNA in plasma of patients with sepsis: a potential diagnostic methodology. , 2020, Discovery medicine.

[28]  D. Tian,et al.  MEG3 Alleviated LPS-Induced Intestinal Injury in Sepsis by Modulating miR-129-5p and Surfactant Protein D , 2020, Mediators of inflammation.

[29]  S. Thein,et al.  Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease , 2019, PloS one.

[30]  Wen-gang Yang,et al.  Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction. , 2019, International immunopharmacology.

[31]  S. Thein,et al.  Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises. , 2019, Cytokine.

[32]  L. Rauova,et al.  Understanding how Fc-modification transforms a pathogenic HIT-like monoclonal antibody into a novel treatment for sepsis. , 2019, Blood.

[33]  F. Meziani,et al.  DNA‐bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Marshall,et al.  Comparison of the source and prognostic utility of cfDNA in trauma and sepsis , 2019, Intensive Care Medicine Experimental.

[35]  Andrew P. Vreede,et al.  Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome , 2019, Nature Communications.

[36]  C. A. Speck-Hernandez,et al.  Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis , 2019, Critical Care.

[37]  S. Chollet-Martin,et al.  Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome , 2019, Anesthesiology.

[38]  B. Chong,et al.  Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia , 2019, Nature Communications.

[39]  Mark J. Miller,et al.  Neutrophil extracellular trap fragments stimulate innate immune responses that prevent lung transplant tolerance , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  T. West,et al.  Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia , 2018, Critical Care.

[41]  S. Maharaj,et al.  Anti-PF4/heparin antibodies are increased in hospitalized patients with bacterial sepsis. , 2018, Thrombosis research.

[42]  Endre Kiss,et al.  Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease , 2018, Nature Communications.

[43]  L. Rauova,et al.  Neutrophil accumulation and NET release contribute to thrombosis in HIT. , 2018, JCI insight.

[44]  P. Libby,et al.  Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&agr; and Cathepsin G , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[45]  N. Takeyama,et al.  Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock , 2018, Critical Care.

[46]  Toshiyuki Shimizu,et al.  Mechanisms controlling nucleic acid-sensing Toll-like receptors , 2018, International immunology.

[47]  Andrew D. Johnson,et al.  The genetics of platelet count and volume in humans , 2018, Platelets.

[48]  J. Michel,et al.  Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke , 2018, Stroke.

[49]  C. Chung,et al.  PAD4 Deficiency Leads to Decreased Organ Dysfunction and Improved Survival in a Dual Insult Model of Hemorrhagic Shock and Sepsis , 2018, The Journal of Immunology.

[50]  J. V. van Woensel,et al.  Local dornase alfa treatment reduces NETs-induced airway obstruction during severe RSV infection , 2017, Thorax.

[51]  B. McDonald,et al.  Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. , 2017, Blood.

[52]  Fang-yu Wang,et al.  Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease , 2017, Medicine.

[53]  R. Pawlinski,et al.  In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. , 2017, Blood.

[54]  O. McCarty,et al.  Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen , 2017, Thrombosis and Haemostasis.

[55]  D. Wagner,et al.  PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model , 2016, Biology of reproduction.

[56]  A. Blom,et al.  Decreased Neutrophil Extracellular Trap Degradation in Shiga Toxin-Associated Haemolytic Uraemic Syndrome , 2016, Journal of Innate Immunity.

[57]  C. Chung,et al.  Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model , 2016, Journal of Innate Immunity.

[58]  V. D’Agati,et al.  Peptidyl arginine deiminase-4-deficient mice are protected against kidney and liver injury after renal ischemia and reperfusion. , 2016, American journal of physiology. Renal physiology.

[59]  Takashi Ito,et al.  DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. , 2016, Blood reviews.

[60]  M. Ulanova,et al.  NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways , 2016, Front. Immunol..

[61]  F. Cunha,et al.  Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis , 2016, PloS one.

[62]  L. Moldawer,et al.  The future of murine sepsis and trauma research models , 2015, Journal of leukocyte biology.

[63]  C. Ronco,et al.  The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis , 2015, Blood Purification.

[64]  D. Dwivedi,et al.  Delayed but not Early Treatment with DNase Reduces Organ Damage and Improves Outcome in a Murine Model of Sepsis , 2015, Shock.

[65]  P. Kubes,et al.  Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature , 2015, Nature Communications.

[66]  J. Belperio,et al.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. , 2015, American journal of respiratory and critical care medicine.

[67]  Gerrit Sitters,et al.  Effect of Temperature on the Intrinsic Flexibility of DNA and Its Interaction with Architectural Proteins , 2014, Biochemistry.

[68]  B. Gillespie,et al.  Neutrophil Extracellular Trap–Derived Enzymes Oxidize High‐Density Lipoprotein: An Additional Proatherogenic Mechanism in Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[69]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice , 2014, Annals of the rheumatic diseases.

[70]  M. Pencina,et al.  Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care , 2014, PloS one.

[71]  P. Thompson,et al.  Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis , 2014, Circulation research.

[72]  D. Angus,et al.  Epidemiology of severe sepsis , 2013, Virulence.

[73]  I. Verhamme,et al.  Factor XI anion‐binding sites are required for productive interactions with polyphosphate , 2013, Journal of thrombosis and haemostasis : JTH.

[74]  U. Pendurthi,et al.  Analysis of tissue factor expression in various cell model systems: cryptic vs. active , 2013, Journal of thrombosis and haemostasis : JTH.

[75]  O. McCarty,et al.  Factor XII promotes blood coagulation independent of factor XI in the presence of long‐chain polyphosphates , 2013, Journal of thrombosis and haemostasis : JTH.

[76]  J. Hodgin,et al.  Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.

[77]  D. Wagner,et al.  Neutrophil extracellular traps , 2013, Oncoimmunology.

[78]  K. Preissner,et al.  Structural Requirements for the Procoagulant Activity of Nucleic Acids , 2012, PloS one.

[79]  P. Kubes,et al.  Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. , 2012, Cell host & microbe.

[80]  D. Cook,et al.  Prognostic utility and characterization of cell-free DNA in patients with severe sepsis , 2012, Critical Care.

[81]  S. Baldus,et al.  Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice , 2012, Critical Care.

[82]  A. Cardona,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[83]  S. Watson,et al.  Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia. , 2012, Blood.

[84]  A. Komissarov,et al.  Effects of Extracellular DNA on Plasminogen Activation and Fibrinolysis* , 2011, The Journal of Biological Chemistry.

[85]  Michael R. Lindberg,et al.  PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.

[86]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[87]  R. Austin,et al.  Development of a continuous assay for the measurement of tissue factor procoagulant activity on intact cells , 2010, Laboratory Investigation.

[88]  F. Newall,et al.  Age‐related plasma reference ranges for two heparin‐binding proteins – vitronectin and platelet factor 4 , 2009, International journal of laboratory hematology.

[89]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[90]  J. Filep,et al.  Bacterial DNA Activates Endothelial Cells and Promotes Neutrophil Adherence through TLR9 Signaling1 , 2009, The Journal of Immunology.

[91]  P. V. von Hippel,et al.  Spectroscopic studies of position-specific DNA “breathing” fluctuations at replication forks and primer-template junctions , 2009, Proceedings of the National Academy of Sciences.

[92]  M. Vilardell‐Tarrés,et al.  DNase 1 and systemic lupus erythematosus. , 2008, Autoimmunity reviews.

[93]  M. Poncz,et al.  Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge. , 2007, Blood.

[94]  L. Rauova,et al.  Heparin‐induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassembly , 2007, Journal of clinical apheresis.

[95]  V. Wahn,et al.  Novel cell death program leads to neutrophil extracellular traps , 2007, The Journal of Cell Biology.

[96]  C. Morris,et al.  Use of dornase alfa in the management of ARDS , 2004, Anaesthesia.

[97]  L. Rauova,et al.  Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. , 2004, Blood.

[98]  U. Wahn,et al.  Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. , 2004, American journal of respiratory and critical care medicine.

[99]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[100]  W. Kisiel,et al.  Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. , 2000, Blood.

[101]  I. McInnes,et al.  Recombinant human Dnase I (rhDNase) in patients with lupus nephritis , 1999, Lupus.

[102]  A. Cantin DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice. , 1998, American journal of respiratory and critical care medicine.

[103]  S. Shak,et al.  The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone , 1996, Clinical and experimental immunology.

[104]  S. Shak,et al.  Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. , 1992, JAMA.

[105]  I. Katz,et al.  Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[106]  P. D. de Groot,et al.  Thrombin-induced release of von Willebrand factor from endothelial cells is mediated by phospholipid methylation. Prostacyclin synthesis is independent of phospholipid methylation. , 1984, The Journal of biological chemistry.

[107]  J. Lieberman Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. , 1968, JAMA.

[108]  E. Witebsky,et al.  Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections. , 1961, JAMA.

[109]  A. Tsung,et al.  Neutrophil Elastase and Neutrophil Extracellular Traps in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.

[110]  T. Renné,et al.  Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[111]  D. Wagner,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS PAD 4-de fi ciency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock , 2015 .

[112]  S. Surrey,et al.  Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. , 1982, Hemoglobin.